Inhibition of fatty acid synthase is protective in pulmonary hypertension.

about

Central Role of Metabolism in Endothelial Cell Function and Vascular Disease.Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains

P2860

Q39137289-EDFEAECD-E70A-43D0-A500-27C911D6D083 Q57091761-1D374BDA-262C-44C1-A561-9C4FD2F51C63

P2860

Inhibition of fatty acid synthase is protective in pulmonary hypertension.

Item

http://www.wikidata.org/entity/Q36941262

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Inhibition of fatty acid synthase is protective in pulmonary hypertension.

@en

type

Item

label

Inhibition of fatty acid synthase is protective in pulmonary hypertension.

@en

prefLabel

Inhibition of fatty acid synthase is protective in pulmonary hypertension.

@en

P1476

Inhibition of fatty acid synthase is protective in pulmonary hypertension.

@en

P2093

Amit Manhas

http://www.w3.org/2001/XMLSchema#string

Gurpreet Kaur

http://www.w3.org/2001/XMLSchema#string

Kashif Hanif

http://www.w3.org/2001/XMLSchema#string

Kumaravelu Jagavelu

http://www.w3.org/2001/XMLSchema#string

Neetu Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Fatty acid synthesis: a potential selective target for antineoplastic therapy

IRS1-independent defects define major nodes of insulin resistance

Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

The Concise Guide to PHARMACOLOGY 2015/16: Transporters

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

The Concise Guide to PHARMACOLOGY 2015/16: Overview

P304

2030-2045

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.13495

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27061087

http://www.w3.org/2001/XMLSchema#string

P921

fatty acid

P932

4882492

http://www.w3.org/2001/XMLSchema#string

Inhibition of fatty acid synthase is protective in pulmonary hypertension.

about

P2860

P2860

Inhibition of fatty acid synthase is protective in pulmonary hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932